The EMJ Podcast | Episode 131
In this week’s episode, Jonathan Sackier is joined by Annalisa Jenkins, a biopharma thought leader with over 25 years of experience in the industry. The pair discuss Jenkins’ time in the Royal Navy, her role as non-executive director of Genomics England, and how connecting human and financial capital can help create an environment conducive to success.
Annalisa Jenkins completed her medical education at Saint Bartholomew’s Medical School, London, followed by a fellowship at the Royal College of Physicians, London, UK. She was a medical officer in the British Royal Navy. She has served in a variety of senior roles at Bristol Myers Squibb, as well as Merck Serono. She is a board member of several growing companies, including Oncimmune, AVROBIO, COMPASS Pathways, AOBiome, AgeX; a medical trustee for the British Heart Foundation; a committee member of the Science Board to the U.S. Food and Drug Administration (FDA); advisory board member at FasterCures; and Chair of Court at the London School of Hygiene and Tropical Medicine.